Wednesday, January 19, 2022, San Francisco, California, 7:15 PM – 8:45 PM Pacific Time (10:15 PM – 11:45 PM Eastern Time)

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Colorectal Cancer

Part 1 of a 3-Part CME Symposia Series Held in Conjunction with the 2022 Gastrointestinal Cancers Symposium

Location
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Program Schedule — Pacific Time
7:00 PM – 7:15 PM — Registration
7:15 PM – 8:45 PM — Educational Dinner Meeting

Meeting Room
Golden Gate Ballroom - Salon A (B2 Level)


This event will also be webcast live.
Please see Registration tab for details.
There is no registration fee for this event. For the in-person symposium in San Francisco, CA, preregistration is required as seating is limited.  
 
Faculty
Faculty to be announced.


Moderator
To be announced.



This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Lilly, Natera Inc and Taiho Oncology Inc.
Program Schedule — Pacific Time
7:00 PM – 7:15 PM — Registration
7:15 PM – 8:45 PM — Educational Dinner Meeting

MODULE 1: Current and Future Role of Therapies Targeting BRAF and HER2 in Metastatic Colorectal Cancer (mCRC)

MODULE 2: Integration of Immune Checkpoint Inhibitors into the Management of mCRC

MODULE 3: Selection and Sequencing of Therapy for Patients with Multiregimen-Relapsed mCRC

MODULE 4: Other Considerations in the Treatment of CRC; Promising Investigational Strategies

Target Audience
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.

Learning Objectives
Upon completion of this activity, participants should be able to

  • Optimize the use of adjuvant chemotherapy for patients with localized colorectal cancer (CRC), considering various clinical and biologic factors (age, performance status, stage, et cetera).
  • Develop a long-term plan to guide the selection and sequencing of therapy for patients diagnosed with metastatic CRC (mCRC), considering biomarker profile, tumor location, prior systemic therapy, symptomatology and personal goals of treatment.
  • Appreciate published research documenting the efficacy of combined BRAF/EGFR inhibition for patients with relapsed/refractory mCRC and a BRAF V600E mutation, and optimally incorporate this therapeutic strategy into clinical care.
  • Recognize available data with anti-HER2 therapy for patients with HER2-positive mCRC, and consider the current and future role of various investigational approaches.
  • Evaluate available data with and the FDA approvals of immune checkpoint inhibitor therapies for microsatellite instability-high or mismatch repair-deficient mCRC, and select appropriate patients for these approaches.
  • Apply available and emerging research to optimize the selection and sequencing of later-line therapeutic options for patients with multiregimen-relapsed mCRC.
  • Recall ongoing trials evaluating novel agents and strategies for CRC, and refer appropriate patients for participation.

CME Credit Form
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Research To Practice designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Content Validation and Disclosures
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.

Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose.

Supporters
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, Lilly, Natera Inc and Taiho Oncology Inc.

San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103
Hotel Phone: (415) 896-1600

Meeting Room
Golden Gate Ballroom - Salon A (B2 Level)

Directions
The San Francisco Marriott Marquis is located just 2 blocks (less than 0.2 miles) from the Moscone Convention Center where the 2022 Gastrointestinal Cancers Symposium is taking place.

 
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.

There is no fee to participate in this program or live webcast of this event.

Registration for in-person meeting

In order to attend this in-person event, please register here.

Registration for event »
 
Registration for live broadcast

Please note we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions.

Registration for Webcast »

Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.

 

Not official events of the 2022 ASCO Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.